Immunometabolism and the Kinome Peptide Array: A New Perspective and Tool for the Study of Gut Health by Ryan J. Arsenault & Michael H. Kogut
MINI REVIEW
published: 13 October 2015
doi: 10.3389/fvets.2015.00044
Edited by:
Carl James Yeoman, Montana State
University, USA
Reviewed by:
Franck Carbonero, University of
Arkansas, USA
Isis Kanevsky-Mullarky, Virginia Tech,
USA
Lindsey Eve Hulbert, Kansas State
University, USA
*Correspondence:
Ryan J. Arsenault
rja@udel.edu
Specialty section:
This article was submitted to
Veterinary Infectious Diseases,
a section of the
journal Frontiers in Veterinary Science
Received: 03 August 2015
Accepted: 28 September 2015
Published: 13 October 2015
Citation:
Arsenault RJ and Kogut MH (2015)
Immunometabolism and the kinome
peptide array: a new perspective and
tool for the study of gut health.
Front. Vet. Sci. 2:44.
doi: 10.3389/fvets.2015.00044
Immunometabolism and the kinome
peptide array: a new perspective and
tool for the study of gut health
Ryan J. Arsenault1* and Michael H. Kogut2
1 Department of Animal and Food Sciences, University of Delaware, Newark, DE, USA, 2 United States Department of
Agriculture, Agricultural Research Service, Southern Plains Agricultural Research Center, College Station, TX, USA
Immunometabolism is a relatively new research perspective, focusing on both
metabolism and immunology and the cross-talk between these biological processes.
Immunometabolism can be considered from two perspectives; 1) the role that immune
cells play in organ metabolism and metabolic disease, and 2) the metabolic processes
that occur within immune cells and how they affect overall immunity. The gut may be the
prototypical organ of immunometabolism. The gut is the site of nutrient absorption and is
a major, if not the major, immune organ. We also describe the integration of kinomics and
the species-specific peptide array to the study of the gut. This unique immunometabolic
tool combined with the unique immunometabolic nature of the gut provides significant
research potential to many animal health applications.
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IMMUNOMETABOLISM
The interface of the immune system andmetabolism is an emerging field of study. Relatively recently,
immunity and metabolism were treated as distinct processes carried out by an organism. Immunity
was focused on the recognition and resistance to a pathogen and involved its own set of cells and
tissue activities. Metabolism was solely the chemical processes that provided the energy to carry out
the various functions of the organism; this included immune functions, but metabolism was simply
the source of energy for the immune system.
The perspective linking immunity and metabolism is styled as immunometabolism.
Immunometabolism can be considered from two sides: 1) the role of immune cells in metabolism
in organs and the effects on whole organism metabolism or 2) the role of metabolic pathways in
immune cells and the effect on broader immunity (1). Early studies in immunometabolism from
the first perspective involved human health concerns related to obesity, diabetes, and metabolic
disorder (2). Excessive fat deposition can lead to an innate immune inflammatory response.
Chronic low-grade inflammation has been linked to metabolic diseases, such as type 2 diabetes,
fatty liver disease, and atherosclerosis. Studies typifying the second perspective involved the role of
some of the classic metabolic energy sensors and energy switches, such as the signaling proteins
AKT1–3, AMPK, mTOR, and LKB1; these were shown to be linked to CD8+ T cell (3) and other
immune cell functions. From there, links between metabolism, immunity, and host response to
infectious disease grew.
Within animal agriculture, a consideration of immunometabolism in animal production has been
ongoing, though not coined as such. It has been clear to poultry producers that a focus solely
on maximizing animal growth can be detrimental to immune potential, while an innate immune
response has negative consequences on growth (4). Integrating metabolism and immunity provides
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a research avenue for the ultimate goal of maximizing growth
and animal production without having a negative impact on
animal health and immunity. Our own research has shown
the nearly innumerable links between cellular signaling pro-
teins classically characterized as members of either the immune
or metabolic functional groups (5). Due to these links, we
feel that an integrated immunometabolic approach is worth
considering for anyone researching animal production from
either a nutrition/metabolism or immunity/disease perspective.
Below, we describe some research categories that fall under the
immunometabolism umbrella and their relevance to animal agri-
culture.
Growth/Immunity Balance
A significant avenue of research combining immunity and
metabolism in animal production was howmounting an immune
response affected energy levels and the transfer of energy from
growth to immunity (4). Research into the energy consequences
of immunity is relatively advanced in animal science. It has been
well understood for many decades that an animal that initiates
an innate immune/inflammatory response will likely grow slower
and have worse feed conversion (6, 7). It is thought that one mode
of action of growth-promoting antibiotics given to food animals
is a general reduction in inflammation. Indeed, it has been argued
that the anti-inflammatory effects of growth-promoting antibi-
otics are evenmore important than their reduction/elimination of
disease-causing pathogens (8). In human medicine, disease early
in life has been linked to ultimate growth potential. Less incidence
of disease as infants results in greater growth and ultimate height
in adulthood (9).
Obesity, Inflammation, Immunity, and
Metabolism
With growing research into obesity and associated ailments,
including metabolic syndrome, diabetes, and heart disease, a
new perspective on the interaction of immunity and metabolism
emerged (10). It was found that chronic low-level inflammation
was a symptom of obesity (11); this inflammation could lead to
diseases like diabetes, among other ailments.
In the animal science field, feed-induced inflammation has
been a concern. Certain feed ingredients can lead to an inflamma-
tory gut response; examples include non-digestible components of
wheat and rye in chickens (12) and soybean meal in fish (13, 14).
Even an excess of feed can lead to changes in immune response
(15). One current animal feed strategy involves adding enzymes
to break down certain indigestible and/or inflammatory feed com-
ponents in the gut, with the aim to reduce immune response and
redirect this energy to growth (16). A current feed trend involves
trying to find natural additives that enhance the animal’s resis-
tance to disease, either by influencing the host immune response
or the gut microbiota. Cautionmust be exercised when evaluating
these feed additives; robust scientific methodology must be used
to determine efficacy and understand the mechanism of action.
In dairy cattle, the transition period immediately before and
after calving is an important immunometabolic period. During
this time, a dairy cow’s immune functions are impaired, as the
mobilization of lipids causes susceptibility to both metabolic and
infectious disease (17). This increase in fatty acids (FAs) in the
blood can lead to uncontrolled inflammation and oxidative stress.
The dysfunction in the inflammatory response, due to the free FAs
increase, is the link betweenmetabolism and immunity during the
calving period.
In poultry, there has been a significant amount of research
into nutrition’s effects on immunity (18) and the use of pre-
and probiotic feed ingredients to improve growth and disease
resistance (19–21). However, the literature is limited on the
immunometabolism link between stress or disease and produc-
tion issues. The links between disease and production issues are
certainly there, and poultry production problems ranging from
lameness (22) to muscle fat deposition (23) have been explored.
As discussed in the following section, the study of
immunometabolism now incorporates the metabolic pathway
changes in immune effector cells, such as macrophages and
T-cells that lead to changes in their activation or immune activity.
A promising new avenue of research is the targeting of metabolic
machinery and metabolic pathways of immune cells as an
alternative means of modulating the immune response.
Intracellular Immunometabolism
Interactions
The recent expansion of the immunometabolism field involves
characterizing the direct intracellular pathway links between
metabolism and immunity (1, 24). Research is focusing on signal-
ing molecules that integrate both metabolic energy sensing and
immune response signals; some examples include mTOR, AMPK,
and sirtuins. The protein synthesis pathway is regulated by mTOR
and is also involved in T-cell fate (25), determining whether
the cell becomes an effector T-cell or a regulatory T-cell (3).
AMPK is an energy sensor that monitors the ratio of AMP:ATP,
altering anabolic and catabolic processes; it is also involved in
innate immune response and has a direct link to mTOR (26). Evi-
dence also points to metabolic-induced epigenetic reprograming
of immune pathways via the sirtuins (27). The past perspective of
separating immunity and metabolism meant a focus on targeting
immune pathways in infectious disease andmetabolism pathways
for growth/metabolic disorders. With an integrated approach, we
can broaden our potential targets for disease intervention and our
understanding of how metabolic processes can influence health.
Oxidative Phosphorylation, Glycolysis,
Warburg Effect, and Immune Response
Studies of the metabolism of immune cells have shown that
metabolic processes determine immune function. In dendritic
cells and macrophages, the switch from oxidative phosphory-
lation (OXPHOS) to aerobic glycolysis, which can be triggered
by immune ligands like LPS, leads to profound immune activity
changes (24). These changes include a release of proinflamma-
tory cytokines, an increase in cell migration, and the utilization
of OXPHOS machinery (28, 29) for the production of immune
effectors such as nitric oxide (NO) and reactive oxygen species
(ROS) (30, 31). In fact, without the change to aerobic glycolysis
initiated by immune ligands, the electron transport chain proteins
in the mitochondria would not be available to generate these
potent antibacterial molecules. The change in metabolism when
Frontiers in Veterinary Science | www.frontiersin.org October 2015 | Volume 2 | Article 442
Arsenault and Kogut Immunometabolism and gut health
immune cells are activated has been described as akin to theWar-
burg effect in cancerous cells, leading to aerobic glycolysis-fueled
proliferation and activity (32).
T-Cells and Metabolism
In T-cells, the metabolic processes that are activated can help
determine the ultimate function of the cell. Effector T-cells
undergo active glycolysis, utilizing this energy to carry out
immune activities and proliferate. Quiescent T-cells rely on gly-
colysis, the citric acid cycle, and OXPHOS (1). Memory T cell
metabolism is biased toward free FA metabolism, and the prolif-
erative machinery is turned off. This gives memory T-cells a lower
metabolic rate and a longer life span, allowing them to survive and
circulate longer than effector T-cells (33).
IMMUNOMETABOLISM AND THE GUT
The gut is the prototypical organ for considering immunity and
metabolism as an integrated whole. The gastrointestinal system
is the site of significant food breakdown and nutrient absorption,
and it is the largest lymphoid organ in the body secreting the most
antibodies in humans (34) and animals (35).
In the production of food animals, the gut is a major focus.
Effective and efficient nutrient absorption is the first and major
step in cost-effective animal production.With the gut as the site of
nutrient absorption, any defect in the ability to extract nutrients
from feed can have a profound impact on growth and disease sus-
ceptibility. In addition, feed efficiency is of critical importance to
animal producers, as higher feed efficiency increases the amount
of commodity produced and reduces costs. Any increases in feed
efficiency from an animal perspective must take place in the gut.
The gut is a major, if not the major, immune organ. It is the
main mucosal immune site, and a majority of a body’s immune
tissue and immunoglobulin producing cells are found in the gut.
Infections of the gastrointestinal tract can have huge implications
on animal health, gut function, meat contamination, and the
spread of disease. A large proportion of disease-causing microbes
in food animals enter the host via the gut (36).Manipulation of the
gut is a multi-billion dollar target for animal industry products,
including prebiotics, probiotics, antibiotics, anti-parasitics, feed
enzymes, and feed additives, among others.Many of the pathogens
that are considered a food safety concern originate or reside in the
animal gut. A proper understanding of the gut can lead to more
efficient animal production, less disease, and safer food.
The microbiome, the central component of gut
physiology, should be considered in any discussion of
the gut and immunometabolism. The microbiome is a key
nutritional/metabolic component of the gut, as gut microbes
break down otherwise indigestible components of food,
providing absorbable and further digestible metabolites (37).
The microbiome is an immune component of the gut, as the
resident microbes are competitors for pathogens that enter the
gut (37, 38). Adding microbes or altering the ratio of microbe
species in the animal gut to competitively exclude pathogens is
undergoing a significant amount of research and development.
The commensal microbes are also critical to proper stimulation
and development of the neonatal immune system and help the
gut immune system to maintain a balance between tolerance and
active immune response (38, 39).
IMMUNOMETABOLISM AND THE KINOME
PEPTIDE ARRAY
Species-Specific Peptide Arrays for
Kinome Analysis
Peptide arrays have become a productive, high-throughput
method of studying the active kinome, the kinase complement of
a cell or tissue (40). The principle involves immobilized kinase-
target peptide sequences printed on a glass array. Exposing the
array to lysate containing active kinases, from gut tissue, for
example, results in peptide phosphorylation and can generate
a visual signal of substrate–enzyme phosphorylation. By com-
paring the relative signal of experimental cell or tissue samples,
one can identify changes in signal transduction pathways and
phosphorylation-regulated events.
It is often the case that new, high-throughput methodologies
are designed for the standard laboratory species, mice, and rats,
or for work with human samples. This was also the case with
the kinome peptide arrays. Through extensive research and devel-
opment, a methodology for designing and using species-specific
kinome arrays was developed (41–43). The use of this technology
in agricultural species has been reviewed extensively elsewhere
(44) and has been used to design peptide arrays to study impor-
tant biological questions in a number of agriculturally important
species, including bovine (45) and poultry (46).
Immunometabolism Array
Not only are the peptide arrays designed to be species-specific
but also they can be process-specific. The initial species-specific
arrays were designed to study the innate immune response and
contained numerous signaling pathways intermediates involved in
this response, such as toll-like receptor (TLR) signaling members,
inflammatory intermediates, and others (45). Subsequently, in
order to study the metabolic consequences of stress responses, a
metabolic peptide array was designed. This array incorporated
protein, carbohydrate, and FA metabolic signaling intermediates
as well as key energy regulating proteins (23, 47). We have con-
ducted numerous studies on the physiology and host–pathogen
interactions in agricultural species using the species-specific pep-
tide arrays. Our analysis of these data showed that the metabolism
and immune processes may be distinctions without differences, in
that they are two integrated parts of a single cellular process (5). It
became clear how much protein–protein interaction there was in
the pathways represented on each array. This level of interaction
was the impetus for our design of an immunometabolic, species-
specific peptide array for both poultry (chicken and turkey) and
cattle. This latest generation of species-specific peptide arrays
provides an integrated immunometabolic approach to studying
kinome response (5). These large arrays, representing approxi-
mately 1,000 individual peptides, have been designed to cover
the entire network of immunometabolism, including innate and
adaptive immunity, protein, carbohydrate, and FA metabolism,
as well as hormone and stress response. This integrated peptide
array will allow for the study of both the immune and metabolic
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consequences of an environmental condition, disease, treatment,
additive or intervention, and the interactions between them.
In the realm of animal agriculture, nutrition/metabolism and
immune performance have been two fields that have been con-
verging for many years. Producers, veterinarians, and animal sci-
entists have come to understand that a sole focus on growth can
often come at the expense of health and disease susceptibility,
and a strong response to disease can have significant effects on
growth.With a tool that can study bothmetabolism and immunity
simultaneously, these two areas of animal science no longer have
to be at odds. We can study nutrition and observe effects on
immune responses or, conversely, study disease and see how this
may effect growth. Our group has already published data that
show that Salmonella infection of chicken can have effects on
the fat deposition and carbohydrate metabolism in peripheral
muscle (23). The results indicated that the dysbiosis caused by
the Salmonella in the gut effected metabolic processes in the
skeletal muscle. We are currently working on projects to in which
we hope to show an immunometabolic response to infectious
diseases and feed-induced inflammation of the gut. This rep-
resents only a small fraction of the research potential of this
approach.
CONCLUSION
The search for antibiotic alternatives in animal production has
renewed the research focus on gut health. It seems likely that any
effective alternative will center in the gut. Immunometabolismhas
expanded from the study of chronic, low-level inflammation, and
obesity to a full research perspective, encompassing a variety of
fields. The adaption of kinomics to animal agriculture is a rela-
tively recent development and has provided valuable insight into
animal biology. Integrating gut health, immunometabolism, and
kinomics have significant potential in animal production/health,
feed additive development, drug discovery, reproduction, and
disease research. Here, we have described this new perspective in
gut health and animal production research and a useful tool to
carry it out.
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